STAT3 and graft versus host disease: Altogether, Li, Wang, et al. propose STAT3 degradation as an attractive strategy for controlling GVHD while maintaining potent GVL activity as well as an interesting concept in which tissue-specific T cell dysfunction explains the distinct effects of STAT3 loss on harmful and beneficial T cell responses (6).